Search research articles
Contact Us
Filters
Showing results (61-70 of 81) with videos related to
Page
of 9
Sort By:
Biochimica Et Biophysica Acta
|
January 22, 2008
Therapeutic attenuation of mitochondrial dysfunction and oxidative stress in neurotoxin models of Parkinson's disease
Edward C Stack, Joellyn L Ferro, Jinho Kim, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases
|
August 9, 2008
Phase 2 study of sodium phenylbutyrate in ALS
Merit E Cudkowicz, Patricia L Andres, Sally A Macdonald, et al.
The Journal of Biological Chemistry
|
April 6, 2006
Sp1 is up-regulated in cellular and transgenic models of Huntington disease, and its reduction is neuroprotective
Zhihua Qiu, Fran Norflus, Bhupinder Singh, et al.
The Journal of Biological Chemistry
|
February 26, 2009
SCAMP5 links endoplasmic reticulum stress to the accumulation of expanded polyglutamine protein aggregates via endocytosis inhibition
Jee-Yeon Noh, Huikyong Lee, Sungmin Song, et al.
Cell Reports
|
December 4, 2012
The sirtuin 2 inhibitor AK-7 is neuroprotective in Huntington's disease mouse models
Vanita Chopra, Luisa Quinti, Jinho Kim, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 14, 2011
The melatonin MT1 receptor axis modulates mutant Huntingtin-mediated toxicity
Xin Wang, Ana Sirianni, Zhijuan Pei, et al.
Biochimica Et Biophysica Acta
|
May 13, 2010
Reduced creatine kinase as a central and peripheral biomarker in Huntington's disease
Jinho Kim, Daniel J Amante, Jennifer P Moody, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 9, 2013
MAP kinase phosphatase 1 (MKP-1/DUSP1) is neuroprotective in Huntington's disease via additive effects of JNK and p38 inhibition
David M Taylor, Roger Moser, Etienne Régulier, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases
|
June 23, 2010
Uridine ameliorates the pathological phenotype in transgenic G93A-ALS mice
Daniel J Amante, Jinho Kim, Samantha T Carreiro, et al.
Neurobiology of Disease
|
March 30, 2013
Melatonin inhibits the caspase-1/cytochrome c/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis
Yi Zhang, Anna Cook, Jinho Kim, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 81) with videos related to
Sort By:
Page
of 9
Biochimica Et Biophysica Acta
|
January 22, 2008
Therapeutic attenuation of mitochondrial dysfunction and oxidative stress in neurotoxin models of Parkinson's disease
Edward C Stack, Joellyn L Ferro, Jinho Kim, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases
|
August 9, 2008
Phase 2 study of sodium phenylbutyrate in ALS
Merit E Cudkowicz, Patricia L Andres, Sally A Macdonald, et al.
The Journal of Biological Chemistry
|
April 6, 2006
Sp1 is up-regulated in cellular and transgenic models of Huntington disease, and its reduction is neuroprotective
Zhihua Qiu, Fran Norflus, Bhupinder Singh, et al.
The Journal of Biological Chemistry
|
February 26, 2009
SCAMP5 links endoplasmic reticulum stress to the accumulation of expanded polyglutamine protein aggregates via endocytosis inhibition
Jee-Yeon Noh, Huikyong Lee, Sungmin Song, et al.
Cell Reports
|
December 4, 2012
The sirtuin 2 inhibitor AK-7 is neuroprotective in Huntington's disease mouse models
Vanita Chopra, Luisa Quinti, Jinho Kim, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 14, 2011
The melatonin MT1 receptor axis modulates mutant Huntingtin-mediated toxicity
Xin Wang, Ana Sirianni, Zhijuan Pei, et al.
Biochimica Et Biophysica Acta
|
May 13, 2010
Reduced creatine kinase as a central and peripheral biomarker in Huntington's disease
Jinho Kim, Daniel J Amante, Jennifer P Moody, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
February 9, 2013
MAP kinase phosphatase 1 (MKP-1/DUSP1) is neuroprotective in Huntington's disease via additive effects of JNK and p38 inhibition
David M Taylor, Roger Moser, Etienne Régulier, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases
|
June 23, 2010
Uridine ameliorates the pathological phenotype in transgenic G93A-ALS mice
Daniel J Amante, Jinho Kim, Samantha T Carreiro, et al.
Neurobiology of Disease
|
March 30, 2013
Melatonin inhibits the caspase-1/cytochrome c/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis
Yi Zhang, Anna Cook, Jinho Kim, et al.
Page
of 9